|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions |
ISO |
Mefloquine inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC4 protein affects the export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16004972 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
increases export multiple interactions |
ISO |
ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein daidzein inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; hesperetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; naringenin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Quercetin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; resveratrol inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; Silymarin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]; verlukast inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein] |
CTD |
PMID:16156793 |
|
NCBI chr11:93,975,579...94,071,659
Ensembl chr11:80,473,872...80,567,253
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects transport multiple interactions increases export increases transport |
EXP ISO |
ABCC2 protein affects the transport of 5(6)-carboxy-2',7'-dichlorofluorescein 4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Ascorbic Acid inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]]; Ascorbic Acid promotes the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Benzbromarone inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Calcium deficiency inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; cyanoginosin LR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Cyclosporine inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin RR inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; microcystin-LF inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Probenecid inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Tobacco Smoke Pollution inhibits the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog] ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein analog [ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein; ABCC2 gene mutant form inhibits the reaction [ABCC2 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein]; ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein; Atorvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Fluvastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Pravastatin promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]; Simvastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:19326901 PMID:21240898 PMID:21341280 PMID:23562342 PMID:24907646 PMID:24909372 PMID:24973091 PMID:25862123 PMID:27450509 PMID:31348918 More...
|
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions increases transport |
EXP ISO |
[ABCC2 gene mutant form results in increased expression of ABCC3 protein] which results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein Benzbromarone inhibits the reaction [ABCC3 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] |
CTD |
PMID:24907646 PMID:31348918 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
multiple interactions increases uptake increases transport |
ISO |
Benzbromarone inhibits the reaction [ABCC5 protein results in increased transport of 5(6)-carboxy-2',7'-dichlorofluorescein] ABCC5 protein results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein |
CTD |
PMID:31348918 PMID:35066093 |
|
NCBI chr11:93,975,579...94,071,659
Ensembl chr11:80,473,872...80,567,253
|
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions increases uptake increases transport |
ISO |
Niclosamide inhibits the reaction [SLC22A8 protein results in increased uptake of 4-carboxyfluorescein]; Novobiocin inhibits the reaction [SLC22A8 protein results in increased uptake of 4-carboxyfluorescein]; quercetin 3'-sulfate inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide analog inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein]; quercetin 3-O-glucuronide inhibits the reaction [SLC22A8 protein results in increased transport of 4-carboxyfluorescein] |
CTD |
PMID:21244849 PMID:38280639 |
|
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
ABCC2 protein affects the transport of [5-chloromethylfluorescein co-treated with Glutathione] |
CTD |
PMID:16049127 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases export |
ISO |
ABCC1 protein results in increased export of 6-carboxyfluorescein |
CTD |
PMID:17940500 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects export multiple interactions |
ISO |
ABCC2 protein affects the export of 6-carboxyfluorescein Probenecid inhibits the reaction [ABCC2 protein affects the export of 6-carboxyfluorescein] |
CTD |
PMID:11477083 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions increases uptake increases import |
ISO |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A6 protein results in increased import of 6-carboxyfluorescein]; Unithiol analog inhibits the reaction [SLC22A6 protein results in increased uptake of 6-carboxyfluorescein] |
CTD |
PMID:20237588 PMID:28629854 |
|
NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
increases import increases uptake multiple interactions |
ISO |
SLC22A8 protein results in increased import of 6-carboxyfluorescein SLC22A8 protein results in increased uptake of 6-carboxyfluorescein 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine promotes the reaction [2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 2-amino-9H-pyrido(2,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; 2-amino-9H-pyrido(2,3-b)indole promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]]; 3-amino-1-methyl-5H-pyrido(4,3-b)indole inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Cadmium Chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; glutaric acid promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; lead chloride promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Probenecid inhibits the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; sodium arsenate promotes the reaction [SLC22A8 protein results in increased import of 6-carboxyfluorescein]; Unithiol analog inhibits the reaction [SLC22A8 protein results in increased uptake of 6-carboxyfluorescein] |
CTD |
PMID:20237588 PMID:28629854 |
|
NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:205,498,084...205,517,450
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions decreases expression |
ISO |
[mangostin co-treated with MK 2206] results in decreased expression of ACTA2 protein; diphenyleneiodonium promotes the reaction [mangostin results in decreased expression of ACTA2 protein]; mangostin promotes the reaction [diphenyleneiodonium results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [mangostin results in decreased expression of ACTA2 protein] mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein] |
CTD |
PMID:30502394 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
affects localization |
ISO |
mangostin affects the localization of AIFM1 protein |
CTD |
PMID:24480042 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
mangostin results in decreased phosphorylation of AKT1 protein [mangostin co-treated with MK 2206] results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:23954321 PMID:30502394 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
mangostin inhibits the reaction [APP protein binds to APP protein] |
CTD |
PMID:38552766 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
mangostin results in increased expression of BAX protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
mangostin results in decreased expression of BCL2 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bid |
BH3 interacting domain death agonist |
decreases expression |
ISO |
mangostin results in decreased expression of BID protein |
CTD |
PMID:24480042 |
|
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased activity of CASP3 protein] |
CTD |
PMID:26357513 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
ISO |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] |
CTD |
PMID:24480042 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
mangostin results in increased activity of CASP8 protein |
CTD |
PMID:24480042 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
mangostin results in increased activity of CASP9 protein |
CTD |
PMID:23954321 PMID:24480042 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
mangostin results in increased expression of CYCS protein |
CTD |
PMID:24480042 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions decreases expression affects response to substance |
ISO |
ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein] mangostin results in decreased expression of ESR1 protein ESR1 protein affects the susceptibility to mangostin |
CTD |
PMID:24480042 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of GPT protein] |
CTD |
PMID:30502394 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hdac1 |
histone deacetylase 1 |
increases expression |
ISO |
mangostin results in increased expression of HDAC1 protein |
CTD |
PMID:30502394 |
|
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hmgb1 |
high mobility group box 1 |
decreases secretion multiple interactions |
ISO |
mangostin results in decreased secretion of HMGB1 protein mangostin inhibits the reaction [Carbon Tetrachloride results in increased expression of HMGB1 protein] diphenyleneiodonium promotes the reaction [mangostin results in decreased secretion of HMGB1 protein]; mangostin affects the localization of and results in decreased acetylation of HMGB1 protein; mangostin promotes the reaction [diphenyleneiodonium results in decreased secretion of HMGB1 protein]; SIRT3 protein affects the reaction [mangostin results in decreased secretion of HMGB1 protein] |
CTD |
PMID:30502394 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAP2K1 protein |
CTD |
PMID:28722351 |
|
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAP2K2 protein |
CTD |
PMID:28722351 |
|
NCBI chr 7:9,241,449...9,264,216
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAP2K4 protein |
CTD |
PMID:28722351 |
|
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK1 protein mangostin analog results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
mangostin results in decreased expression of and results in decreased phosphorylation of MAPK3 protein mangostin analog results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:23954321 PMID:28722351 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:28722351 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
ISO |
mangostin analog results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:28722351 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP2 protein] mangostin analog results in decreased expression of MMP2 mRNA; mangostin analog results in decreased expression of MMP2 protein |
CTD |
PMID:28722351 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions |
ISO |
mangostin analog results in decreased expression of MMP9 mRNA; mangostin analog results in decreased expression of MMP9 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein]; pyrazolanthrone inhibits the reaction [mangostin analog results in decreased expression of MMP9 protein] |
CTD |
PMID:28722351 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
mangostin results in increased cleavage of PARP1 protein |
CTD |
PMID:23954321 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
mangostin inhibits the reaction [Isoproterenol results in increased expression of PTGS2 protein] |
CTD |
PMID:18424012 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sirt3 |
sirtuin 3 |
increases expression multiple interactions |
ISO |
mangostin results in increased expression of SIRT3 protein SIRT3 protein affects the reaction [mangostin results in decreased expression of ACTA2 protein]; SIRT3 protein affects the reaction [mangostin results in decreased secretion of HMGB1 protein] [mangostin co-treated with Carbon Tetrachloride] results in increased expression of and results in increased secretion of SIRT3 protein |
CTD |
PMID:30502394 |
|
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:195,942,073...195,964,808
|
|
G |
Tff1 |
trefoil factor 1 |
decreases expression |
ISO |
mangostin results in decreased expression of TFF1 protein |
CTD |
PMID:24480042 |
|
NCBI chr20:9,237,095...9,240,956
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
mangostin inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:18424012 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
mangostin results in increased expression of TP53 protein mangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of TP53 mRNA] |
CTD |
PMID:24480042 PMID:26357513 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of ADAM17 mRNA] |
CTD |
PMID:37528096 |
|
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:40,872,856...40,920,639
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of AKT1 mRNA]; bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of and results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:36518482 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Brd4 |
bromodomain containing 4 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of BRD4 mRNA]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of BRD4 protein] |
CTD |
PMID:37528096 |
|
NCBI chr 7:11,866,997...11,946,575
Ensembl chr 7:11,216,446...11,295,539
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein] |
CTD |
PMID:37127800 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
bellidifolin results in increased expression of CASP3 protein |
CTD |
PMID:33299414 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
bellidifolin results in increased expression of CASP8 protein |
CTD |
PMID:33299414 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
decreases expression |
ISO |
bellidifolin results in decreased expression of CEBPB mRNA |
CTD |
PMID:33299414 |
|
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Gck |
glucokinase |
decreases activity |
ISO |
bellidifolin results in decreased activity of GCK protein |
CTD |
PMID:19962285 |
|
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
EXP |
bellidifolin results in increased expression of GCLC mRNA; bellidifolin results in increased expression of GCLC protein |
CTD |
PMID:30800665 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gsdmd |
gasdermin D |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of GSDMD protein alternative form]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GSDMD protein] |
CTD |
PMID:37127800 |
|
NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:107,542,083...107,547,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of GSK3B mRNA]; bellidifolin inhibits the reaction [Hydrogen Peroxide results in increased expression of GSK3B protein] |
CTD |
PMID:36518482 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
bellidifolin results in increased expression of HMOX1 mRNA; bellidifolin results in increased expression of HMOX1 protein |
CTD |
PMID:30800665 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL18 protein] |
CTD |
PMID:37127800 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased secretion of IL1B protein] |
CTD |
PMID:37127800 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Insr |
insulin receptor |
increases expression |
ISO |
bellidifolin results in increased expression of INSR |
CTD |
PMID:19962285 |
|
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Irs1 |
insulin receptor substrate 1 |
increases expression |
ISO |
bellidifolin results in increased expression of IRS1 |
CTD |
PMID:19962285 |
|
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Myh7 |
myosin heavy chain 7 |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of MYH7 protein] |
CTD |
PMID:37528096 |
|
NCBI chr15:32,416,525...32,439,851
Ensembl chr15:28,446,550...28,468,217
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NLRP3 protein] |
CTD |
PMID:37127800 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NOX4 mRNA]; bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NOX4 protein] |
CTD |
PMID:37528096 |
|
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nppa |
natriuretic peptide A |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPA protein] |
CTD |
PMID:37528096 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:158,429,042...158,430,351
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of NPPB protein] |
CTD |
PMID:37528096 |
|
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of and affects the localization of NR4A1 protein] |
CTD |
PMID:33995055 |
|
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases expression |
ISO |
bellidifolin results in decreased expression of PARP1 protein |
CTD |
PMID:33299414 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
decreases expression |
ISO |
bellidifolin results in decreased expression of PTGER2 mRNA |
CTD |
PMID:33299414 |
|
NCBI chr15:20,694,765...20,708,475
Ensembl chr15:18,217,285...18,228,714
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
decreases expression |
ISO |
bellidifolin results in decreased expression of PTGER4 mRNA |
CTD |
PMID:33299414 |
|
NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:54,335,424...54,346,670
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
bellidifolin results in decreased expression of PTGS2 protein |
CTD |
PMID:33299414 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pycard |
PYD and CARD domain containing |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of PYCARD protein] |
CTD |
PMID:37127800 |
|
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of SMAD2 protein] |
CTD |
PMID:33995055 |
|
NCBI chr18:72,124,792...72,193,345
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:33995055 PMID:35586685 |
|
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Smad4 |
SMAD family member 4 |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SMAD4 protein] |
CTD |
PMID:33995055 |
|
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
multiple interactions |
ISO |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SOX9 protein] bellidifolin inhibits the reaction [Isoproterenol results in increased expression of SOX9 protein] |
CTD |
PMID:35586685 |
|
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions decreases expression |
ISO |
bellidifolin results in decreased expression of and results in decreased phosphorylation of STAT3 protein bellidifolin results in decreased expression of STAT3 mRNA |
CTD |
PMID:33299414 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SMAD4 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SOX9 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of SMAD2 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR1 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR2 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of SMAD4 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of and affects the localization of NR4A1 protein]; bellidifolin inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:33995055 PMID:35586685 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
multiple interactions |
EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR1 protein] |
CTD |
PMID:33995055 |
|
NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:61,653,233...61,710,777
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
multiple interactions |
EXP |
bellidifolin inhibits the reaction [TGFB1 protein results in increased expression of and results in increased phosphorylation of TGFBR2 protein] |
CTD |
PMID:33995055 |
|
NCBI chr 8:124,672,677...124,761,741
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP ISO |
bellidifolin inhibits the reaction [Isoproterenol results in increased expression of TNF mRNA] |
CTD |
PMID:37528096 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases export multiple interactions increases secretion |
ISO |
ABCB1 protein results in increased export of fluorexon Amiodarone inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Clotrimazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Cyclosporine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Ketoconazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Miconazole inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Reserpine inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon]; Troleandomycin inhibits the reaction [ABCB1A protein results in increased secretion of fluorexon] [carvedilol results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; [Verapamil results in decreased activity of ABCB1 protein] which results in increased uptake of fluorexon; Beclomethasone inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Clotrimazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Cyclosporine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; desisobutyrylciclesonide inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Ketoconazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Miconazole inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Mometasone Furoate inhibits the reaction [ABCB1 protein results in increased export of fluorexon]; Reserpine inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Troleandomycin inhibits the reaction [ABCB1 protein results in increased secretion of fluorexon]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of fluorexon] |
CTD |
PMID:10571255 PMID:12235267 PMID:16442095 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects export increases export increases import affects transport multiple interactions |
ISO |
ABCC1 protein affects the export of fluorexon ABCC1 protein results in increased export of fluorexon ABCC1 protein results in increased import of fluorexon ABCC1 protein affects the transport of fluorexon [Glycyrrhetinic Acid affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [Indomethacin affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [matairesinol affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; [verlukast affects the activity of ABCC1 protein] which results in increased abundance of fluorexon; Mefloquine inhibits the reaction [ABCC1 protein affects the export of fluorexon]; nobiletin promotes the reaction [ABCC1 protein results in increased import of fluorexon]; Quercetin inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; robinetin inhibits the reaction [ABCC1 protein affects the export of fluorexon]; Silymarin inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein affects the export of fluorexon]; verlukast inhibits the reaction [ABCC1 protein results in increased export of fluorexon]; Vincristine inhibits the reaction [ABCC1 protein affects the transport of fluorexon] |
CTD |
PMID:10685512 PMID:15670588 PMID:16004972 PMID:16156793 PMID:18204840 PMID:18955043 PMID:26454883 More...
|
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects export increases abundance multiple interactions affects transport |
ISO |
ABCC2 protein affects the export of fluorexon ABCC2 protein alternative form results in increased abundance of fluorexon robinetin inhibits the reaction [ABCC2 protein affects the export of fluorexon] ABCC2 protein affects the transport of fluorexon |
CTD |
PMID:15670588 PMID:15848949 PMID:22027652 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
affects transport |
ISO |
ABCC6 affects the transport of fluorexon |
CTD |
PMID:14667841 |
|
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:96,447,251...96,501,464
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
affects export multiple interactions |
ISO |
ABCB11 protein affects the export of calcein AM ditekiren inhibits the reaction [ABCB11 protein affects the export of calcein AM] |
CTD |
PMID:10617675 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects export increases export multiple interactions increases activity increases transport increases secretion |
ISO EXP |
ABCB1 protein affects the export of calcein AM ABCB1 protein results in increased export of calcein AM ABCB1A protein promotes the reaction [Emodin results in increased export of calcein AM] 2-methoxy-N-(3-(4-((3-methyl-4-((6-methyl-3-pyridinyl)oxy)phenyl)amino)-6-quinazolinyl)-2-propenyl)acetamide inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [Endosulfan co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [phosalone co-treated with Verapamil] inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; [pinostrobin results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; [tectochrysin results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; [Verapamil binds to and results in decreased activity of ABCB1 protein] inhibits the reaction [sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]]; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of calcein AM; ABCB1 protein affects the reaction [Mifepristone results in decreased transport of calcein AM]; ABCB1 protein affects the reaction [zosuquidar trihydrochloride results in decreased transport of calcein AM]; Atorvastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; chlorpyrifos-methyl affects the reaction [ABCB1 protein results in increased transport of calcein AM]; Cyclosporine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; deoxynivalenol inhibits the reaction [valspodar inhibits the reaction [ABCB1 protein results in increased export of calcein AM]]; Diazinon inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Diazinon promotes the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Diazinon promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Endosulfan inhibits the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Endosulfan promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; fenoxycarb inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; fenvalerate inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; phosalone inhibits the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; phosalone inhibits the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; propiconazole inhibits the reaction [phosalone inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Endosulfan inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; propiconazole promotes the reaction [Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]]; Reserpine inhibits the reaction [ABCB1 protein affects the export of calcein AM]; Simvastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; sodium arsenite promotes the reaction [ABCB1 protein results in increased secretion of calcein AM]; spinosad inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; valspodar inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of calcein AM]; Verapamil inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; Verapamil promotes the reaction [propiconazole inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]] calcein AM results in increased activity of ABCB1 protein mutant form |
CTD |
PMID:10617675 PMID:12711602 PMID:15616150 PMID:16121039 PMID:19223659 PMID:19549930 PMID:21321059 PMID:21783720 PMID:29174985 PMID:30217652 PMID:37259354 More...
|
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
increases transport multiple interactions |
ISO |
ABCC1 protein results in increased transport of calcein AM [ABCC1 protein results in increased susceptibility to Silver Nitrate] which results in decreased export of calcein AM; [ABCC1 protein results in increased susceptibility to Silver] which results in decreased export of calcein AM; [MLN 8237 results in decreased activity of ABCC1 protein] which results in decreased export of calcein AM; [MYC protein results in increased expression of ABCC1 protein] which results in increased export of calcein AM; [verlukast results in decreased activity of ABCC1 protein] which results in decreased export of calcein AM; verlukast inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; zearalenol metabolite inhibits the reaction [ABCC1 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC1 protein results in increased transport of calcein AM] |
CTD |
PMID:19239227 PMID:19647055 PMID:27376922 PMID:34896433 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects transport multiple interactions increases transport increases export |
ISO EXP |
ABCC2 protein affects the transport of calcein AM Atorvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Simvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM] [MYC protein results in increased expression of ABCC2 protein] which results in increased export of calcein AM; Atorvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; montelukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; Simvastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased export of calcein AM]; verlukast inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; zearalenol inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC2 protein results in increased transport of calcein AM] |
CTD |
PMID:15210835 PMID:15616150 PMID:19239227 PMID:19647055 PMID:19952419 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
affects transport multiple interactions increases transport |
ISO |
ABCC3 protein affects the transport of calcein AM Dexamethasone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Glutathione promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Hydrocortisone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; Prednisone promotes the reaction [ABCC3 protein affects the transport of calcein AM]; verlukast inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; zearalenol inhibits the reaction [ABCC3 protein results in increased transport of calcein AM]; Zearalenone inhibits the reaction [ABCC3 protein results in increased transport of calcein AM] |
CTD |
PMID:15210835 PMID:15979871 PMID:19647055 |
|
NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions |
ISO |
Glutathione promotes the reaction [ABCC4 protein affects the transport of calcein AM] |
CTD |
PMID:15210835 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Abcc6 |
ATP binding cassette subfamily C member 6 |
multiple interactions |
ISO |
Glutathione promotes the reaction [ABCC6 protein affects the transport of calcein AM] |
CTD |
PMID:15210835 |
|
NCBI chr 1:105,583,681...105,637,895
Ensembl chr 1:96,447,251...96,501,464
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[MYC protein results in increased expression of ABCC1 protein] which results in increased export of calcein AM; [MYC protein results in increased expression of ABCC2 protein] which results in increased export of calcein AM |
CTD |
PMID:19239227 |
|
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
|
|
|
G |
Aanat |
aralkylamine N-acetyltransferase |
multiple interactions |
EXP |
Cannabinol inhibits the reaction [Norepinephrine results in increased activity of AANAT protein] |
CTD |
PMID:16805813 |
|
NCBI chr10:101,827,072...101,831,805
Ensembl chr10:101,827,301...101,831,801
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
ISO |
Cannabinol results in decreased activity of ABCC1 protein |
CTD |
PMID:18619955 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
affects binding |
EXP |
Cannabinol binds to CNR1 protein |
CTD |
PMID:19679411 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:48,408,574...48,435,099
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
multiple interactions increases metabolic processing |
ISO |
Cannabinol inhibits the reaction [CYP2J2 protein results in increased metabolism of anandamide] CYP2J2 protein results in increased metabolism of Cannabinol |
CTD |
PMID:29689453 |
|
NCBI chr 5:116,295,691...116,323,219
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol results in decreased expression of and affects the localization of FOS protein |
CTD |
PMID:10670588 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
Cannabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; Rimonabant inhibits the reaction [Cannabinol inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]] |
CTD |
PMID:11520904 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL2 mRNA]; Cannabinol inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL2 protein]; Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein]; KN 93 inhibits the reaction [Cannabinol promotes the reaction [Tetradecanoylphorbol Acetate results in increased secretion of IL2 protein]] |
CTD |
PMID:8662742 PMID:10670588 PMID:11809870 |
|
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[JUN protein binds to FOS protein] which binds to IL2 promoter]; Cannabinol results in decreased expression of and affects the localization of JUN protein |
CTD |
PMID:10670588 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Prl |
prolactin |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased expression of PRL mRNA]; Cannabinol inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol co-treated with Colforsin] results in increased secretion of PRL protein] |
CTD |
PMID:31154070 |
|
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
Cannabinol inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased phosphorylation of and results in increased activity of STAT1 protein] |
CTD |
PMID:19910459 |
|
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity multiple interactions |
ISO |
Cannabinol results in increased activity of TRPA1 protein [Cannabinol results in increased activity of TRPA1 protein] which results in increased uptake of Calcium |
CTD |
PMID:31096838 |
|
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
multiple interactions |
EXP |
Cannabinol binds to and results in increased activity of TRPV2 protein |
CTD |
PMID:18550765 |
|
NCBI chr10:47,772,223...47,797,956
Ensembl chr10:47,272,931...47,294,260
|
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNB1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased expression of IRF3 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides affects the phosphorylation of and affects the expression of and affects the localization of JUN protein] |
CTD |
PMID:31350693 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in decreased expression of NFKBIA protein] |
CTD |
PMID:31350693 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:31350693 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ticam1 |
TIR domain containing adaptor molecule 1 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of TICAM1 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,102,366...1,123,147
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:31350693 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
cudratricusxanthone A inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] |
CTD |
PMID:31350693 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] |
CTD |
PMID:34655103 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:34655103 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased secretion of MUC5AC protein] |
CTD |
PMID:34655103 |
|
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of MYD88 protein] |
CTD |
PMID:34655103 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
euxanthone inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:34655103 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects export |
ISO |
ABCC1 protein affects the export of Fluo-3 |
CTD |
PMID:15948026 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions increases secretion |
EXP |
Adenosine Triphosphate promotes the reaction [ABCC2 protein results in increased secretion of Fluo-3]; Cyclosporine inhibits the reaction [ABCC2 protein results in increased secretion of Fluo-3] |
CTD |
PMID:9794919 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
multiple interactions |
ISO |
[CYP2C19 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein; Tranylcypromine inhibits the reaction [[CYP2C19 protein results in increased metabolism of dibenzylfluorescein] which results in increased chemical synthesis of Fluorescein] |
CTD |
PMID:23850985 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Fluorescein results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Slc22a6 |
solute carrier family 22 member 6 |
multiple interactions |
ISO |
Fluorescein inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:11602689 |
|
NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:205,522,729...205,531,173
|
|
G |
Slco1b2 |
solute carrier organic anion transporter family member 1B2 |
increases uptake multiple interactions |
ISO |
SLCO1B3 protein results in increased uptake of Fluorescein bisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; bisphenol F promotes the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; Probenecid inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein]; tetrabromobisphenol A inhibits the reaction [SLCO1B3 protein results in increased uptake of Fluorescein] |
CTD |
PMID:27989701 |
|
NCBI chr 4:176,282,577...176,355,557
Ensembl chr 4:174,551,480...174,619,981
|
|
G |
Slco3a1 |
solute carrier organic anion transporter family, member 3a1 |
increases uptake multiple interactions |
ISO |
SLCO3A1 protein results in increased uptake of Fluorescein Cyclosporine promotes the reaction [SLCO3A1 protein results in increased uptake of Fluorescein]; simvastatin acid affects the reaction [SLCO3A1 protein results in increased uptake of Fluorescein] |
CTD |
PMID:28887287 |
|
NCBI chr 1:128,106,232...128,388,043
Ensembl chr 1:128,106,228...128,387,925
|
|
|
G |
Abcb7 |
ATP binding cassette subfamily B member 7 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ABCB7 protein |
CTD |
PMID:27129696 |
|
NCBI chr X:73,361,296...73,502,464
Ensembl chr X:69,295,552...69,436,858
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of AKR1C2 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Anxa4 |
annexin A4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ANXA4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:119,184,374...119,241,161
|
|
G |
Arhgap6 |
Rho GTPase activating protein 6 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ARHGAP6 protein |
CTD |
PMID:27129696 |
|
NCBI chr X:28,525,912...29,062,344
Ensembl chr X:24,953,464...25,488,663
|
|
G |
Azi2 |
5-azacytidine induced 2 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to AZI2 protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:126,651,268...126,674,795
Ensembl chr 8:117,773,279...117,797,847
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CAPZB protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
|
|
G |
Cd109 |
CD109 molecule |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CD109 protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:88,334,736...88,449,463
Ensembl chr 8:79,454,480...79,569,194
|
|
G |
Cd180 |
CD180 molecule |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CD180 protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:35,589,889...35,602,837
Ensembl chr 2:33,855,991...33,899,936
|
|
G |
Cd86 |
CD86 molecule |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of CD86 protein |
CTD |
PMID:19665512 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cd93 |
CD93 molecule |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CD93 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:156,345,019...156,351,537
Ensembl chr 3:135,891,859...135,898,378
|
|
G |
Cdc20 |
cell division cycle 20 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to CDC20 protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Copa |
COPI coat complex subunit alpha |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to COPA protein |
CTD |
PMID:27129696 |
|
NCBI chr13:87,078,853...87,119,256
Ensembl chr13:84,545,943...84,586,874
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of CYP1A1 mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Dcaf4 |
DDB1 and CUL4 associated factor 4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to DCAF4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982
|
|
G |
Dot1l |
DOT1 like histone lysine methyltransferase |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to DOT1L protein |
CTD |
PMID:27129696 |
|
NCBI chr 7:9,569,439...9,607,095
Ensembl chr 7:8,917,786...8,956,475
|
|
G |
Elac1 |
elaC ribonuclease Z 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ELAC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr18:69,596,475...69,617,206
Ensembl chr18:67,323,583...67,340,936
|
|
G |
Enpp7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to ENPP7 protein |
CTD |
PMID:27129696 |
|
NCBI chr10:104,740,763...104,745,760
Ensembl chr10:104,242,223...104,246,589
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to FLRT3 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:127,994,491...128,008,137
Ensembl chr 3:127,994,226...128,007,841
|
|
G |
Fn1 |
fibronectin 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to FN1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of HMOX1 protein [Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of HMOX1 protein |
CTD |
PMID:27871981 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to HSPA5 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa9 |
heat shock protein family A (Hsp70) member 9 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to HSPA9 protein |
CTD |
PMID:27129696 |
|
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,535,798...26,554,292
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein; [Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IFNG protein; [Fluorescein-5-isothiocyanate co-treated with tricaproin] results in increased secretion of IFNG protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IFNG protein |
CTD |
PMID:29198882 PMID:36870414 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IKBKB protein |
CTD |
PMID:27129696 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Ikzf4 |
IKAROS family zinc finger 4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IKZF4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 7:1,643,379...1,687,524
Ensembl chr 7:1,056,890...1,084,341
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
[Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IL17A protein |
CTD |
PMID:36870414 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il17re |
interleukin 17 receptor E |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IL17RE protein |
CTD |
PMID:27129696 |
|
NCBI chr 4:148,160,384...148,173,830
Ensembl chr 4:146,605,526...146,618,206
|
|
G |
Il31ra |
interleukin 31 receptor A |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to IL31RA protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:45,851,073...45,922,300
Ensembl chr 2:44,122,624...44,183,767
|
|
G |
Il4 |
interleukin 4 |
multiple interactions increases expression |
ISO |
[Dibutyl Phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; [dibutyrylglycerol analog co-treated with Fluorescein-5-isothiocyanate] affects the secretion of IL4 protein; [Fluorescein-5-isothiocyanate co-treated with tributyrin] results in increased secretion of IL4 protein; [Fluorescein-5-isothiocyanate co-treated with tricaproin] results in increased secretion of IL4 protein; [tributyrin co-treated with Fluorescein-5-isothiocyanate] results in increased secretion of IL4 protein; diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of IL4 protein]] |
CTD |
PMID:27871981 PMID:29198882 PMID:36870414 |
|
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Lypd3 |
Ly6/Plaur domain containing 3 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to LYPD3 protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:80,226,449...80,230,901
Ensembl chr 1:80,226,449...80,230,901
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Map3k20 |
mitogen-activated protein kinase kinase kinase 20 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to MAP3K20 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:57,130,539...57,289,943
Ensembl chr 3:57,130,551...57,289,626
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK1 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK1 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:27129696 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK3 protein Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK3 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:27129696 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation |
ISO |
Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK8 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:27129696 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions increases phosphorylation |
ISO |
Fluorescein-5-isothiocyanate inhibits the reaction [Dinitrofluorobenzene results in increased phosphorylation of MAPK9 protein]; Fluorescein-5-isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] Fluorescein-5-isothiocyanate results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:27129696 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mt2 |
metallothionein 2 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of MT2A mRNA |
CTD |
PMID:20491607 |
|
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mybpc1 |
myosin binding protein C1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to MYBPC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 7:24,817,770...24,903,681
Ensembl chr 7:22,930,350...23,015,957
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
[Melatonin co-treated with diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased expression of NFE2L2 protein |
CTD |
PMID:27871981 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of NQO1 mRNA Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]; Melatonin inhibits the reaction [diisodecyl phthalate inhibits the reaction [Fluorescein-5-isothiocyanate results in increased expression of NQO1 protein]] |
CTD |
PMID:20491607 PMID:27871981 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Plce1 |
phospholipase C, epsilon 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PLCE1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:245,655,855...245,964,966
Ensembl chr 1:236,244,683...236,551,438
|
|
G |
Postn |
periostin |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to POSTN protein |
CTD |
PMID:27129696 |
|
NCBI chr 2:140,677,774...140,709,304
Ensembl chr 2:138,527,696...138,559,099
|
|
G |
Pprc1 |
PPARG related coactivator 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PPRC1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:244,902,179...244,918,587
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of PRKCB protein |
CTD |
PMID:31958493 |
|
NCBI chr 1:186,263,397...186,594,743
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Psd4 |
pleckstrin and Sec7 domain containing 4 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PSD4 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:7,137,069...7,173,571
Ensembl chr 3:7,137,155...7,173,571
|
|
G |
Psmd14 |
proteasome 26S subunit, non-ATPase 14 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to PSMD14 protein |
CTD |
PMID:27129696 |
|
NCBI chr 3:66,662,933...66,755,666
Ensembl chr 3:46,254,330...46,347,076
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein; Melatonin inhibits the reaction [[diisodecyl phthalate co-treated with Fluorescein-5-isothiocyanate] results in increased phosphorylation of RELA protein] |
CTD |
PMID:27871981 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Scn5a |
sodium voltage-gated channel alpha subunit 5 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to SCN5A protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:119,220,905...119,318,769
|
|
G |
Skor1 |
SKI family transcriptional corepressor 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to SKOR1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:72,494,554...72,505,127
Ensembl chr 8:63,599,165...63,607,756
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
multiple interactions increases uptake |
ISO |
Taurocholic Acid promotes the reaction [SLC10A1 protein results in increased uptake of Fluorescein-5-isothiocyanate] |
CTD |
PMID:32209977 |
|
NCBI chr 6:106,344,319...106,357,944
Ensembl chr 6:100,613,045...100,626,670
|
|
G |
Slc38a10 |
solute carrier family 38, member 10 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to SLC38A10 protein |
CTD |
PMID:27129696 |
|
NCBI chr10:105,885,250...105,935,043
Ensembl chr10:105,386,836...105,436,636
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions increases phosphorylation |
ISO |
diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
multiple interactions increases phosphorylation |
ISO |
diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT5 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
increases phosphorylation multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased phosphorylation of STAT6 protein]] |
CTD |
PMID:27871981 |
|
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to TRPA1 protein |
CTD |
PMID:27129696 |
|
NCBI chr 5:9,163,060...9,217,325
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Tslp |
thymic stromal lymphopoietin |
increases expression multiple interactions |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of TSLP protein diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]; Melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [Fluorescein-5-isothiocyanate results in increased expression of TSLP protein]] |
CTD |
PMID:27871981 |
|
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,449,844...24,453,548
|
|
G |
Txn1 |
thioredoxin 1 |
increases expression |
ISO |
Fluorescein-5-isothiocyanate results in increased expression of TXN mRNA |
CTD |
PMID:20491607 |
|
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Usp3 |
ubiquitin specific peptidase 3 |
affects binding |
ISO |
Fluorescein-5-isothiocyanate binds to USP3 protein |
CTD |
PMID:27129696 |
|
NCBI chr 8:75,973,278...76,049,151
Ensembl chr 8:67,079,927...67,154,111
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein]] |
CTD |
PMID:35901927 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of BCL2 protein] |
CTD |
PMID:35901927 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of BCL2L1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of CAT protein] |
CTD |
PMID:35901927 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of GPX1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:35901927 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:35901927 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
EXP |
gallein inhibits the reaction [Chloroquine affects the localization of SLC2A4 protein] |
CTD |
PMID:27160165 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
|
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
garcinone C inhibits the reaction [APP protein binds to APP protein] |
CTD |
PMID:38552766 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
|
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
garcinone D inhibits the reaction [APP protein binds to APP protein] |
CTD |
PMID:38552766 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
JBIR-99 results in increased expression of BAX protein |
CTD |
PMID:31433962 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
JBIR-99 results in decreased expression of BCL2 protein |
CTD |
PMID:31433962 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
JBIR-99 results in increased expression of CASP3 protein |
CTD |
PMID:31433962 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
JBIR-99 results in increased expression of CYCS protein |
CTD |
PMID:31433962 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
increases expression |
ISO |
JBIR-99 results in increased expression of IKBKB protein |
CTD |
PMID:31433962 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases expression |
ISO |
JBIR-99 results in decreased expression of PARP1 protein |
CTD |
PMID:31433962 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression |
ISO |
JBIR-99 results in increased expression of RELA protein |
CTD |
PMID:31433962 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression multiple interactions |
ISO |
mangiferin results in increased expression of ABCB1 mRNA; mangiferin results in increased expression of ABCB1 protein Dichlororibofuranosylbenzimidazole inhibits the reaction [mangiferin results in increased expression of ABCB1 protein] |
CTD |
PMID:20513373 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
decreases expression |
ISO |
mangiferin results in decreased expression of ABL1 mRNA |
CTD |
PMID:15498116 |
|
NCBI chr 3:35,377,587...35,480,843
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions increases phosphorylation |
EXP |
dorsomorphin inhibits the reaction [mangiferin results in increased phosphorylation of ACACA protein] |
CTD |
PMID:22292039 |
|
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions decreases activity |
ISO |
mangiferin inhibits the reaction [Scopolamine results in decreased expression of ACHE protein] mangiferin results in decreased activity of ACHE protein |
CTD |
PMID:19182383 PMID:22426032 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 8:28,939,984...28,946,639
Ensembl chr 8:20,663,985...20,667,929
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein |
CTD |
PMID:32417366 |
|
NCBI chr16:71,544,603...71,547,410
Ensembl chr16:64,841,788...64,844,552
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
decreases expression |
EXP |
mangiferin results in decreased expression of AGER mRNA; mangiferin results in decreased expression of AGER protein |
CTD |
PMID:24036348 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
mangiferin inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A protein]; mangiferin inhibits the reaction [AGT protein results in increased expression of COL1A1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of COL4A1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 protein]; mangiferin inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 protein] |
CTD |
PMID:17645561 PMID:19706694 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions |
EXP |
mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of AGTR1A protein] |
CTD |
PMID:17645561 PMID:19706694 |
|
NCBI chr17:34,383,397...34,435,523
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of AIFM1 protein] |
CTD |
PMID:19201465 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein] mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:19201465 PMID:22465218 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
affects binding |
ISO |
mangiferin binds to ALB protein |
CTD |
PMID:19157745 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [lead nitrate results in decreased expression of APAF1 protein] |
CTD |
PMID:23451106 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Atp6v0d2 |
ATPase H+ transporting V0 subunit D2 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased expression of BAX protein] mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of BAX protein]; mangiferin inhibits the reaction [lead nitrate results in increased expression of BAX protein] |
CTD |
PMID:19201465 PMID:23451106 PMID:24095822 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA] mangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein] mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]; mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] |
CTD |
PMID:21420233 PMID:22118634 PMID:23451106 PMID:24095822 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of BCL2L1 protein |
CTD |
PMID:21547680 PMID:26996543 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
mangiferin results in decreased expression of BIRC5 protein |
CTD |
PMID:26996543 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
|
|
G |
C3 |
complement C3 |
decreases expression |
ISO |
mangiferin results in decreased expression of C3 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,087,437...2,114,429
|
|
G |
Calcr |
calcitonin receptor |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 4:32,615,955...32,691,075
Ensembl chr 4:31,661,273...31,736,392
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO EXP |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP3 protein] mangiferin inhibits the reaction [aluminum maltolate results in increased activity of CASP3 protein] mangiferin results in increased activity of CASP3 protein mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP3 protein] |
CTD |
PMID:21547680 PMID:22118634 PMID:22310181 PMID:23451106 PMID:26996543 PMID:37455591 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases expression multiple interactions |
ISO |
mangiferin results in increased expression of CASP8 protein mangiferin inhibits the reaction [aluminum maltolate results in increased activity of CASP8 protein] |
CTD |
PMID:32420661 PMID:37455591 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein] mangiferin inhibits the reaction [aluminum maltolate results in increased activity of CASP9 protein] mangiferin inhibits the reaction [Galactosamine results in increased expression of CASP9 protein] |
CTD |
PMID:22118634 PMID:23451106 PMID:37455591 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions increases activity |
ISO EXP |
mangiferin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CAT mRNA]; mangiferin inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; mangiferin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] mangiferin inhibits the reaction [Mercuric Chloride results in decreased expression of CAT protein] mangiferin inhibits the reaction [Cyclophosphamide results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; mangiferin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] mangiferin results in increased activity of CAT protein |
CTD |
PMID:15161907 PMID:16076520 PMID:16584858 PMID:16697266 PMID:17433543 PMID:18816296 PMID:19201465 PMID:20629087 PMID:23451106 PMID:27125760 PMID:29223569 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
mangiferin results in decreased expression of CCL2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein] |
CTD |
PMID:15135318 |
|
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
mangiferin results in increased expression of CCNB1 mRNA |
CTD |
PMID:20518311 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions increases expression |
EXP |
dorsomorphin inhibits the reaction [mangiferin results in increased expression of CD36 protein] |
CTD |
PMID:22292039 |
|
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cdh1 |
cadherin 1 |
increases expression affects expression multiple interactions |
ISO |
mangiferin results in increased expression of CDH1 protein mangiferin affects the expression of CDH1 protein lipopolysaccharide, Escherichia coli O111 B4 affects the reaction [mangiferin affects the expression of CDH1 protein] |
CTD |
PMID:23707762 PMID:32420661 |
|
NCBI chr19:51,402,178...51,471,572
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
ISO |
mangiferin results in increased expression of CDK1 mRNA |
CTD |
PMID:20518311 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein] mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of CHUK protein] mangiferin inhibits the reaction [Galactosamine results in increased phosphorylation of CHUK protein] |
CTD |
PMID:21420233 PMID:22310181 PMID:23451106 |
|
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA |
CTD |
PMID:32417366 |
|
NCBI chr18:63,164,817...63,190,384
Ensembl chr18:60,894,874...60,920,481
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
mangiferin inhibits the reaction [AGT protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
multiple interactions |
EXP |
mangiferin inhibits the reaction [AGT protein results in increased expression of COL4A1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression multiple interactions |
EXP |
mangiferin results in increased expression of CPT1A protein dorsomorphin inhibits the reaction [mangiferin results in increased expression of CPT1A protein] |
CTD |
PMID:22292039 |
|
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions decreases expression |
ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] mangiferin results in decreased expression of CSF2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Csf3 |
colony stimulating factor 3 |
multiple interactions decreases expression |
ISO |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein] mangiferin results in decreased expression of CSF3 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:84,157,485...84,159,860
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases response to substance |
ISO |
CTNNB1 protein results in decreased susceptibility to mangiferin |
CTD |
PMID:23707762 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctnnd1 |
catenin delta 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Paraquat results in decreased expression of and affects the localization of CTNND1 protein]; mangiferin inhibits the reaction [Paraquat results in decreased expression of CTNND1 mRNA alternative form] |
CTD |
PMID:24912632 |
|
NCBI chr 3:90,090,025...90,141,247
Ensembl chr 3:69,683,313...69,734,516
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of CTSD protein] |
CTD |
PMID:19172585 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 2:185,747,548...185,758,512
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
multiple interactions |
ISO |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of CXCR4 protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCR4 mRNA] |
CTD |
PMID:21420233 PMID:32420661 |
|
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
mangiferin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:22815239 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity increases expression |
EXP ISO |
mangiferin results in decreased activity of CYP1A2 protein mangiferin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:18053976 PMID:22815239 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases activity |
EXP |
mangiferin results in increased activity of CYP2B1 protein |
CTD |
PMID:18053976 |
|
NCBI chr 1:90,646,098...90,669,762
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases activity |
EXP |
mangiferin results in decreased activity of CYP2C6 protein |
CTD |
PMID:18053976 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP2D6 protein |
CTD |
PMID:22815239 |
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
EXP |
mangiferin results in decreased activity of CYP2E1 protein |
CTD |
PMID:18053976 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity |
ISO |
mangiferin results in decreased activity of CYP3A4 protein |
CTD |
PMID:22815239 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
decreases activity |
EXP |
mangiferin results in decreased activity of CYP3A23-3A1 protein |
CTD |
PMID:18053976 |
|
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
|
|
G |
Dcstamp |
dendrocyte expressed seven transmembrane protein |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA] |
CTD |
PMID:20683903 |
|
NCBI chr 7:72,692,364...72,706,983
Ensembl chr 7:70,807,581...70,822,078
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
decreases expression affects expression multiple interactions |
EXP |
mangiferin results in decreased expression of DGAT2 protein mangiferin affects the expression of DGAT2 mRNA; mangiferin affects the expression of DGAT2 protein dorsomorphin inhibits the reaction [mangiferin results in increased expression of DGAT2 protein] |
CTD |
PMID:22292039 PMID:25123789 |
|
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Methylmercury Compounds results in increased expression of and results in increased phosphorylation of DNM1L protein] |
CTD |
PMID:28071871 |
|
NCBI chr11:98,084,049...98,135,663
Ensembl chr11:84,581,216...84,631,482
|
|
G |
F10 |
coagulation factor X |
decreases activity |
ISO |
mangiferin analog results in decreased activity of F10 protein |
CTD |
PMID:21732671 |
|
NCBI chr16:83,170,973...83,190,280
Ensembl chr16:76,468,838...76,488,141
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
mangiferin results in increased expression of FAS protein |
CTD |
PMID:17634039 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of FBP1 mRNA |
CTD |
PMID:19028559 |
|
NCBI chr17:2,212,941...2,235,749
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:19706694 |
|
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gcg |
glucagon |
multiple interactions |
EXP |
[mangiferin co-treated with Sitagliptin Phosphate] results in increased expression of GCG protein alternative form |
CTD |
PMID:22948814 |
|
NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:47,113,914...47,122,929
|
|
G |
Glo1 |
glyoxalase 1 |
increases expression multiple interactions |
EXP |
mangiferin results in increased expression of GLO1 mRNA mangiferin results in increased expression of and results in increased activity of GLO1 protein |
CTD |
PMID:24036348 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Streptozocin results in increased activity of GPT protein] |
CTD |
PMID:29223569 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [Benzo(a)pyrene results in decreased activity of GSR protein]; mangiferin inhibits the reaction [lead nitrate results in decreased activity of GSR protein] mangiferin inhibits the reaction [Methylmercury Compounds results in decreased activity of GSR protein] mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GSR protein] |
CTD |
PMID:16697266 PMID:18816296 PMID:23451106 PMID:28071871 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Isoproterenol results in decreased activity of GUSB protein] |
CTD |
PMID:19172585 |
|
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:26,697,951...26,726,905
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of HMOX1 mRNA]]; mangiferin inhibits the reaction [Galactosamine results in decreased expression of HMOX1 protein]; mangiferin inhibits the reaction [Methotrexate results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:22310181 PMID:36249937 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions decreases expression |
ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA] mangiferin results in decreased expression of ICAM1 mRNA |
CTD |
PMID:15135318 PMID:15161907 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Icam2 |
intercellular adhesion molecule 2 |
decreases expression |
ISO |
mangiferin results in decreased expression of ICAM2 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:91,808,449...91,819,319
Ensembl chr10:91,308,538...91,315,293
|
|
G |
Icam5 |
intercellular adhesion molecule 5 |
decreases expression |
ISO |
mangiferin results in decreased expression of ICAM5 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 8:19,567,390...19,575,588
Ensembl chr 8:19,568,600...19,575,588
|
|
G |
Ifna1 |
interferon, alpha 1 |
increases expression |
ISO |
mangiferin results in increased expression of IFNA1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 5:108,143,240...108,143,809
Ensembl chr 5:103,097,356...103,097,925
|
|
G |
Ifnb1 |
interferon beta 1 |
increases expression |
ISO |
mangiferin results in increased expression of IFNB1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Dinoprostone]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Leukotriene B4]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL5 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF3 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein]; mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of IFNG mRNA] |
CTD |
PMID:12694877 PMID:15135318 PMID:15177302 PMID:15177305 PMID:15222974 PMID:16716910 PMID:22310181 More...
|
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein] mangiferin inhibits the reaction [Galactosamine results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:21420233 PMID:22310181 |
|
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Galactosamine results in decreased expression of IL10 mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
decreases expression |
ISO |
mangiferin results in decreased expression of IL12A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 2:155,275,734...155,282,997
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL12B mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL18 mRNA] |
CTD |
PMID:22310181 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
decreases expression |
ISO |
mangiferin results in decreased expression of IL1A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
mangiferin inhibits the reaction [Galactosamine results in increased expression of IL1B mRNA]; mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [Methotrexate results in increased expression of IL1B protein] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein] |
CTD |
PMID:15381052 PMID:22310181 PMID:27125760 PMID:27474068 PMID:36249937 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2rb |
interleukin 2 receptor subunit beta |
decreases expression |
ISO |
mangiferin results in decreased expression of IL2RB mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 7:111,913,828...111,928,537
Ensembl chr 7:110,033,341...110,048,054
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
mangiferin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased secretion of IL6 protein] mangiferin inhibits the reaction [Galactosamine results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [Streptozocin results in increased expression of IL6 protein] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; mangiferin inhibits the reaction [Ketamine results in increased expression of IL6 protein] mangiferin results in decreased expression of IL6 mRNA |
CTD |
PMID:15135318 PMID:21420233 PMID:22310181 PMID:23087136 PMID:27474068 PMID:32420661 PMID:37044004 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
affects expression multiple interactions |
EXP ISO |
mangiferin affects the expression of INS1 protein [mangiferin co-treated with Sitagliptin Phosphate] results in increased expression of INS1 protein; mangiferin inhibits the reaction [Streptozocin results in increased expression of INS1 protein] [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADRB3 protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 protein; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of UCP1 protein |
CTD |
PMID:22948814 PMID:24167738 PMID:32417366 PMID:37044004 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of IRF1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Lpl |
lipoprotein lipase |
multiple interactions increases activity increases expression |
ISO |
MK-886 inhibits the reaction [mangiferin results in increased activity of LPL protein]; MK-886 inhibits the reaction [mangiferin results in increased expression of LPL mRNA] |
CTD |
PMID:15975614 |
|
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
decreases phosphorylation |
ISO |
mangiferin results in decreased phosphorylation of MAP3K14 protein |
CTD |
PMID:26996543 |
|
NCBI chr10:88,665,417...88,715,669
Ensembl chr10:88,165,351...88,215,523
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation decreases activity affects binding multiple interactions |
ISO EXP |
mangiferin results in increased phosphorylation of MAPK1 protein mangiferin metabolite results in decreased activity of MAPK1 protein mangiferin metabolite binds to MAPK1 protein mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19201465 PMID:20683903 PMID:22084399 PMID:22465218 PMID:23451106 PMID:27474068 More...
|
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk10 |
mitogen activated protein kinase 10 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [aluminum maltolate results in increased expression of and results in increased activity of MAPK10 protein] |
CTD |
PMID:37455591 |
|
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,497,707...6,786,201
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases activity increases phosphorylation |
ISO EXP |
mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]; mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] mangiferin metabolite results in decreased activity of MAPK3 protein mangiferin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] mangiferin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK3 protein] mangiferin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:19201465 PMID:20683903 PMID:22084399 PMID:22465218 PMID:23451106 PMID:27474068 More...
|
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
decreases expression |
ISO |
mangiferin results in decreased expression of MAPK8 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases expression |
ISO |
mangiferin results in decreased expression of MAPK9 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Max |
MYC associated factor X |
decreases expression |
ISO |
mangiferin results in decreased expression of MAX mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 6:101,369,989...101,395,333
Ensembl chr 6:95,636,858...95,662,137
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
mangiferin results in decreased expression of MMP7 protein |
CTD |
PMID:23707762 |
|
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions decreases activity |
ISO |
mangiferin results in decreased expression of MMP9 mRNA; mangiferin results in decreased expression of MMP9 protein mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of MMP9 protein] mangiferin results in decreased expression of and results in decreased secretion of MMP9 protein mangiferin results in decreased activity of MMP9 protein |
CTD |
PMID:22465218 PMID:23707762 PMID:27125760 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
mangiferin inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein] |
CTD |
PMID:27125760 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA]]; mangiferin affects the reaction [Galactosamine affects the localization of NFE2L2 protein]; mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFE2L2 protein]; mangiferin inhibits the reaction [Methotrexate results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:22310181 PMID:36249937 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO EXP |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased activity of NFKB1 protein] bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of NFKB1 mRNA]]; mangiferin inhibits the reaction [Methotrexate results in increased expression of NFKB1 mRNA] |
CTD |
PMID:15161907 PMID:36249937 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases expression |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein] mangiferin inhibits the reaction [Galactosamine results in decreased expression of NFKBIA protein] mangiferin results in increased expression of NFKBIA protein mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of NFKBIA protein]; mangiferin inhibits the reaction [lead nitrate results in decreased expression of NFKBIA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein] |
CTD |
PMID:15161907 PMID:20683903 PMID:22310181 PMID:23451106 PMID:27474068 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nfkbib |
NFKB inhibitor beta |
decreases expression multiple interactions |
ISO |
mangiferin results in decreased expression of NFKBIB mRNA mangiferin inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein] |
CTD |
PMID:15135318 PMID:21420233 |
|
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nfkbie |
NFKB inhibitor epsilon |
decreases expression |
ISO |
mangiferin results in decreased expression of NFKBIE mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 9:22,941,037...22,947,872
Ensembl chr 9:15,436,941...15,450,437
|
|
G |
Nfkbil1 |
NFKB inhibitor like 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of NFKBIL1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr20:3,595,319...3,610,295
Ensembl chr20:3,590,642...3,605,616
|
|
G |
Ngf |
nerve growth factor |
increases secretion |
ISO |
mangiferin results in increased secretion of NGF protein |
CTD |
PMID:20303935 |
|
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of NLRP3 protein] |
CTD |
PMID:32420661 |
|
NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP ISO |
bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of NOS2 mRNA]]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of NOS2 protein]; mangiferin inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [Methotrexate results in increased expression of NOS2 mRNA]; mangiferin promotes the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNFB protein] results in increased expression of NOS2 mRNA] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA] |
CTD |
PMID:12694877 PMID:15381052 PMID:22118634 PMID:22310181 PMID:27474068 PMID:36249937 More...
|
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Galactosamine results in decreased expression of NQO1 protein] |
CTD |
PMID:22310181 |
|
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Oga |
O-GlcNAcase |
multiple interactions |
EXP |
bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of OGA protein]]; mangiferin inhibits the reaction [Methotrexate results in increased expression of OGA protein] |
CTD |
PMID:36249937 |
|
NCBI chr 1:254,547,311...254,589,596
Ensembl chr 1:244,598,292...244,634,359
|
|
G |
Per1 |
period circadian regulator 1 |
affects expression multiple interactions |
ISO |
mangiferin affects the expression of PER1 protein mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of PER1 protein] |
CTD |
PMID:32420661 |
|
NCBI chr10:54,299,002...54,313,804
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
decreases activity |
ISO |
mangiferin results in decreased activity of PLA2G2A protein |
CTD |
PMID:15177302 |
|
NCBI chr 5:156,359,725...156,362,302
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions |
EXP |
mangiferin inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions increases activity |
ISO |
MK-886 inhibits the reaction [mangiferin results in increased activity of PPARA protein] [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARA mRNA |
CTD |
PMID:15975614 PMID:32417366 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
EXP ISO |
bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]]; mangiferin inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein |
CTD |
PMID:29223569 PMID:32417366 PMID:36249937 PMID:37044004 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARGC1A protein |
CTD |
PMID:32417366 |
|
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
|
|
G |
Prdm16 |
PR/SET domain 16 |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PRDM16 protein |
CTD |
PMID:32417366 |
|
NCBI chr 5:170,162,275...170,486,371
Ensembl chr 5:164,880,587...165,203,601
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
EXP |
dorsomorphin inhibits the reaction [mangiferin results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; mangiferin results in increased phosphorylation of and results in increased activity of PRKAA1 protein |
CTD |
PMID:22292039 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions affects expression |
ISO EXP |
mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA] mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein] mangiferin inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; mangiferin inhibits the reaction [Methotrexate results in increased expression of PTGS2 protein] mangiferin affects the expression of PTGS2 mRNA |
CTD |
PMID:15161907 PMID:15381052 PMID:18621015 PMID:19026997 PMID:21420233 PMID:27474068 PMID:36249937 More...
|
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Raf1 |
Raf-1 proto-oncogene, serine/threonine kinase |
decreases expression |
ISO |
mangiferin results in decreased expression of RAF1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects localization decreases expression decreases localization |
ISO EXP |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of and results in increased activity of RELA protein] mangiferin affects the localization of RELA protein bisphenol A diglycidyl ether inhibits the reaction [mangiferin inhibits the reaction [Methotrexate results in increased expression of and results in increased phosphorylation of RELA protein]]; mangiferin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [Galactosamine results in increased expression of RELA protein]; mangiferin inhibits the reaction [Methotrexate results in increased expression of and results in increased phosphorylation of RELA protein]; mangiferin inhibits the reaction [Streptozocin results in increased expression of RELA mRNA] mangiferin results in decreased expression of RELA mRNA mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein]; mangiferin inhibits the reaction [lead nitrate results in increased expression of RELA protein]; mangiferin inhibits the reaction [Scopolamine results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased localization of RELA protein] mangiferin results in decreased localization of RELA protein |
CTD |
PMID:15135318 PMID:15161907 PMID:19182383 PMID:19201465 PMID:20683903 PMID:21547680 PMID:22310181 PMID:23451106 PMID:26996543 PMID:27474068 PMID:36249937 PMID:37044004 More...
|
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Relb |
RELB proto-oncogene, NF-kB subunit |
decreases expression |
ISO |
mangiferin results in decreased expression of RELB mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:79,257,725...79,285,507
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of RIPK1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Sele |
selectin E |
decreases expression |
ISO |
mangiferin results in decreased expression of SELE mRNA |
CTD |
PMID:15135318 |
|
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Selplg |
selectin P ligand |
decreases expression |
ISO |
mangiferin results in decreased expression of SELPLG mRNA |
CTD |
PMID:15135318 |
|
NCBI chr12:48,457,102...48,470,444
Ensembl chr12:42,796,580...42,812,585
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A1 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr 1:50,624,339...50,651,437
Ensembl chr 1:48,076,666...48,103,678
|
|
G |
Slc22a12 |
solute carrier family 22 member 12 |
decreases expression |
ISO |
mangiferin results in decreased expression of SLC22A12 mRNA; mangiferin results in decreased expression of SLC22A12 protein |
CTD |
PMID:21348301 |
|
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A2 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
|
|
G |
Slc22a4 |
solute carrier family 22 member 4 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A4 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr10:38,634,098...38,687,409
Ensembl chr10:38,133,322...38,179,720
|
|
G |
Slc22a5 |
solute carrier family 22 member 5 |
increases expression |
ISO |
mangiferin results in increased expression of SLC22A5 mRNA |
CTD |
PMID:21348301 |
|
NCBI chr10:38,509,072...38,536,240
Ensembl chr10:38,008,311...38,035,309
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions increases expression |
ISO EXP |
2-chloro-5-nitrobenzanilide inhibits the reaction [mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]]; mangiferin affects the localization of and results in increased activity of SLC2A4 protein; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Deoxyglucose]; mangiferin promotes the reaction [SLC2A4 protein results in increased uptake of Glucose] mangiferin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; mangiferin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein] mangiferin results in increased expression of SLC2A4 mRNA |
CTD |
PMID:19477051 PMID:29223569 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of SNAI1 protein |
CTD |
PMID:23707762 |
|
NCBI chr 3:176,667,476...176,671,965
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
decreases expression |
ISO |
mangiferin results in decreased expression of SNAI2 protein |
CTD |
PMID:23707762 |
|
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SOD1 mRNA] |
CTD |
PMID:17433543 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases activity |
ISO |
mangiferin results in decreased activity of SRD5A2 protein |
CTD |
PMID:20823678 |
|
NCBI chr 6:27,178,089...27,217,588
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Srf |
serum response factor |
decreases expression |
ISO |
mangiferin results in decreased expression of SRF mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 9:21,924,050...21,933,338
Ensembl chr 9:14,426,472...14,435,733
|
|
G |
Tab1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of TAB1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 7:113,556,157...113,587,351
Ensembl chr 7:111,686,371...111,707,058
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of TBK1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:57,077,830...57,110,892
|
|
G |
Tert |
telomerase reverse transcriptase |
decreases activity |
ISO |
mangiferin results in decreased activity of TERT protein |
CTD |
PMID:17634039 |
|
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO EXP |
mangiferin promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TGFB1 mRNA] mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; mangiferin inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; mangiferin inhibits the reaction [Streptozocin results in increased secretion of TGFB1 protein] |
CTD |
PMID:12694877 PMID:19706694 PMID:19960420 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tlr6 |
toll-like receptor 6 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR6 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr14:43,715,809...43,727,019
Ensembl chr14:43,362,164...43,375,685
|
|
G |
Tlr7 |
toll-like receptor 7 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR7 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr X:30,644,324...30,670,796
Ensembl chr X:27,027,425...27,054,754
|
|
G |
Tlr8 |
toll-like receptor 8 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR8 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr X:30,708,714...30,733,104
Ensembl chr X:27,091,778...27,116,549
|
|
G |
Tlr9 |
toll-like receptor 9 |
decreases expression |
ISO |
mangiferin results in decreased expression of TLR9 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 8:115,743,407...115,747,523
Ensembl chr 8:106,864,680...106,868,796
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression affects expression increases secretion |
ISO EXP |
mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased activity of NFKB1 protein]; mangiferin inhibits the reaction [TNF protein affects the localization of and results in increased phosphorylation of and results in increased activity of RELA protein]; mangiferin inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; mangiferin inhibits the reaction [TNF protein results in increased degradation of NFKBIB protein]; mangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of CXCR4 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of PTGS2 mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA]; mangiferin inhibits the reaction [TNF protein results in increased expression of XIAP mRNA]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased degradation of NFKBIA protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of IKBKB protein]; mangiferin inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]; mangiferin inhibits the reaction [TNF protein results in increased secretion of IL6 protein] mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased expression of NOS2 mRNA]; mangiferin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in increased secretion of NOS2 mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [Galactosamine results in increased expression of TNF protein]; mangiferin inhibits the reaction [Isoproterenol results in increased expression of TNF protein]; mangiferin inhibits the reaction [Methotrexate results in increased expression of TNF protein]; mangiferin inhibits the reaction [Streptozocin results in increased expression of TNF protein] mangiferin results in decreased expression of TNF mRNA mangiferin analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of TNF protein]; mangiferin inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; mangiferin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; mangiferin inhibits the reaction [Scopolamine results in increased expression of TNF protein]; mangiferin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of RELA protein] mangiferin affects the expression of TNF protein mangiferin results in increased secretion of TNF protein |
CTD |
PMID:12694877 PMID:15135318 PMID:15161907 PMID:15177305 PMID:15222974 PMID:19172585 PMID:19182383 PMID:20303935 PMID:21420233 PMID:21837981 PMID:22118634 PMID:22310181 PMID:27125760 PMID:27474068 PMID:36249937 PMID:37044004 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11a |
TNF receptor superfamily member 11A |
decreases expression |
ISO |
mangiferin results in decreased expression of TNFRSF11A mRNA |
CTD |
PMID:15135318 |
|
NCBI chr13:22,442,930...22,501,257
Ensembl chr13:21,928,408...21,986,695
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNFSF11 protein results in increased degradation of NFKBIA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of DCSTAMP mRNA]; mangiferin inhibits the reaction [TNFSF11 protein results in increased localization of RELA protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK1 protein]; mangiferin inhibits the reaction [TNFSF11 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:20683903 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
mangiferin inhibits the reaction [Oxygen deficiency results in increased expression of TP53 protein] |
CTD |
PMID:10657591 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tradd |
TNFRSF1A-associated via death domain |
decreases expression |
ISO |
mangiferin results in decreased expression of TRADD mRNA |
CTD |
PMID:15135318 |
|
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:33,136,138...33,142,638
|
|
G |
Traf6 |
TNF receptor associated factor 6 |
decreases expression |
ISO |
mangiferin results in decreased expression of TRAF6 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:87,963,514...87,983,507
|
|
G |
Ucp1 |
uncoupling protein 1 |
multiple interactions |
ISO |
[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of UCP1 protein |
CTD |
PMID:32417366 |
|
NCBI chr19:41,713,350...41,721,421
Ensembl chr19:24,808,783...24,816,852
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression decreases activity |
ISO |
mangiferin results in increased expression of UGT1A1 mRNA mangiferin results in decreased activity of UGT1A1 protein |
CTD |
PMID:22815239 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases expression |
ISO |
mangiferin results in increased expression of UGT1A9 mRNA |
CTD |
PMID:22815239 |
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
decreases activity |
ISO |
mangiferin results in decreased activity of UGT2B7 protein |
CTD |
PMID:22815239 |
|
NCBI chr14:21,251,535...21,274,451
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Umod |
uromodulin |
affects expression |
ISO |
mangiferin affects the expression of UMOD protein |
CTD |
PMID:21348301 |
|
NCBI chr 1:183,247,676...183,261,665
Ensembl chr 1:173,816,339...173,830,302
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
decreases expression |
ISO |
mangiferin results in decreased expression of VCAM1 mRNA |
CTD |
PMID:15135318 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of VEGFA mRNA] |
CTD |
PMID:21420233 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
ISO |
mangiferin results in decreased expression of VIM protein mangiferin affects the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of VIM protein] |
CTD |
PMID:23707762 PMID:32420661 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions decreases expression |
ISO |
mangiferin inhibits the reaction [TNF protein results in increased expression of XIAP mRNA] mangiferin results in decreased expression of XIAP protein |
CTD |
PMID:21420233 PMID:21547680 PMID:26996543 |
|
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
norathyriol results in increased expression of ABCB1 protein |
CTD |
PMID:20513373 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
affects binding decreases activity |
ISO |
norathyriol binds to MAPK1 protein norathyriol results in decreased activity of MAPK1 protein |
CTD |
PMID:22084399 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases activity |
ISO |
norathyriol results in decreased activity of MAPK3 protein |
CTD |
PMID:22084399 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
norathyriol inhibits the reaction [GW 7647 results in increased activity of PPARA protein] |
CTD |
PMID:18393431 |
|
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
ISO |
norathyriol inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid results in increased activity of PPARD protein] |
CTD |
PMID:18393431 |
|
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein] |
CTD |
PMID:18393431 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
EXP |
norswertianolin results in increased expression of GCLC mRNA; norswertianolin results in increased expression of GCLC protein |
CTD |
PMID:30800665 |
|
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
norswertianolin results in increased expression of HMOX1 mRNA; norswertianolin results in increased expression of HMOX1 protein |
CTD |
PMID:30800665 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
|
G |
Tslp |
thymic stromal lymphopoietin |
multiple interactions |
ISO |
Phloxine O inhibits the reaction [calcipotriol increases expression of Tslp mRNA and protein in skin of external ear and phorbol 12-myristate 13-acetate increases expression of Tslp protein in keratinocytes] |
RGD |
PMID:29310423 |
RGD:38549374 |
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,449,844...24,453,548
|
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
multiple interactions |
ISO |
Propantheline inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:48,121,061...48,163,268
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
psorospermin inhibits the reaction [ABCB1 protein results in decreased susceptibility to Doxorubicin] |
CTD |
PMID:7083125 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions decreases uptake increases export |
ISO EXP |
3-methylquercetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 3-methylquercetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; 5,7-dimethoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5,7-dimethoxyflavone inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; 5-hydroxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5-methoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5-oxo-hexahydroquinoline analog inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; [GSK 1363089 results in decreased activity of ABCB1 protein] which results in decreased export of Rhodamine 123; [Verapamil results in decreased activity of ABCB1 protein] which results in decreased export of Rhodamine 123; [zosuquidar trihydrochloride results in decreased activity of ABCB1 protein] which results in decreased export of Rhodamine 123; abemaciclib inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; baicalein inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; baicalein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; betulin inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; biochanin A inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; biochanin A promotes the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; CEP 33779 inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123]; daidzein inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; flavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; formononetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Genistein promotes the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; glycitein promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; isovitexin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; kaempferol inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; myricetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; naringenin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; naringin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Quercetin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; Quercetin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; quercitrin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Rutin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; tangeretin inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; tangeretin inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; taxifolin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]]; Verapamil inhibits the reaction [ABCB1 protein results in increased export of Rhodamine 123] [P-glycoprotein inducer and activator TX5 results in increased activity of ABCB1 protein] which results in increased export of Rhodamine 123; [Verapamil results in decreased activity of ABCB1 protein] inhibits the reaction [P-glycoprotein inducer and activator TX5 results in increased export of Rhodamine 123] |
CTD |
PMID:25058526 PMID:27816545 PMID:30391378 PMID:31756430 PMID:33321149 PMID:34217736 PMID:34896433 PMID:38367674 More...
|
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions increases export |
ISO |
abemaciclib inhibits the reaction [ABCG2 protein results in increased export of Rhodamine 123] |
CTD |
PMID:27816545 |
|
NCBI chr 4:89,006,056...89,132,915
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Slc22a7 |
solute carrier family 22 member 7 |
increases uptake multiple interactions |
ISO |
SLC22A7 protein results in increased uptake of Rhodamine 123 Desipramine inhibits the reaction [SLC22A7 protein results in increased uptake of Rhodamine 123]; Niclosamide inhibits the reaction [SLC22A7 protein results in increased uptake of Rhodamine 123] |
CTD |
PMID:38280639 |
|
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
|
|
|
G |
Ache |
acetylcholinesterase |
decreases activity |
ISO |
rhodamine 6G results in decreased activity of ACHE protein |
CTD |
PMID:33844597 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity |
ISO |
Rose Bengal results in decreased activity of ABCB1 protein |
CTD |
PMID:20041016 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity |
EXP |
Rose Bengal results in decreased activity of CYP19A1 protein |
CTD |
PMID:18310892 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity |
ISO |
Rose Bengal results in decreased activity of CYP3A4 protein |
CTD |
PMID:20041016 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
decreases response to substance |
EXP |
GSTA3 protein results in decreased susceptibility to Rose Bengal |
CTD |
PMID:1740415 |
|
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Iyd |
iodotyrosine deiodinase |
decreases activity |
ISO |
Rose Bengal results in decreased activity of IYD protein |
CTD |
PMID:24012475 |
|
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:40,004,041...40,019,319
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Rose Bengal results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Klkb1 |
kallikrein B1 |
multiple interactions decreases response to substance |
ISO |
7-Ala-angiotensin (1-7) inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; nimesulide inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal]; splitomicin inhibits the reaction [KLKB1 gene mutant form results in decreased susceptibility to Rose Bengal] |
CTD |
PMID:25339356 |
|
NCBI chr16:53,690,180...53,714,570
Ensembl chr16:46,958,707...46,982,053
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity |
ISO |
Rose Bengal results in decreased activity of UGT1A6 protein |
CTD |
PMID:20041016 |
|
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
affects export affects transport |
ISO |
ABCC1 protein affects the export of vadimezan metabolite ABCC1 protein affects the transport of vadimezan analog |
CTD |
PMID:15282097 PMID:15784341 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
affects transport affects export |
ISO |
ABCC2 protein affects the transport of vadimezan analog ABCC2 protein affects the export of vadimezan metabolite |
CTD |
PMID:15282097 PMID:15784341 |
|
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 protein]] |
CTD |
PMID:37046119 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases oxidation |
ISO |
Acridines analog inhibits the reaction [CYP1A2 protein results in increased oxidation of vadimezan] |
CTD |
PMID:16120190 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of GPT protein]] |
CTD |
PMID:37046119 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Ifnb1 |
interferon beta 1 |
increases expression |
ISO |
vadimezan results in increased expression of IFNB1 mRNA |
CTD |
PMID:36958387 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
EXP |
vadimezan results in increased expression of IL1A protein |
CTD |
PMID:16944150 |
|
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
EXP ISO |
vadimezan results in increased expression of IL6 protein vadimezan results in increased expression of IL6 mRNA vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 protein]] |
CTD |
PMID:16944150 PMID:36958387 PMID:37046119 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Irf3 |
interferon regulatory factor 3 |
increases phosphorylation |
ISO |
vadimezan results in increased phosphorylation of IRF3 protein |
CTD |
PMID:36958387 |
|
NCBI chr 1:104,616,608...104,621,402
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
P2rx1 |
purinergic receptor P2X 1 |
multiple interactions |
ISO |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of RELA protein; [vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of STING1 protein; [vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of TBK1 protein; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of CCL2 protein]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of GPT protein]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of IL6 protein]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF protein]]; vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen] |
CTD |
PMID:37046119 |
|
NCBI chr10:58,117,107...58,132,167
Ensembl chr10:57,618,586...57,633,623
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of RELA protein |
CTD |
PMID:37046119 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
multiple interactions |
ISO |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of STING1 protein |
CTD |
PMID:37046119 |
|
NCBI chr18:27,606,196...27,612,544
Ensembl chr18:27,332,119...27,338,335
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
multiple interactions |
ISO |
[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of TBK1 protein |
CTD |
PMID:37046119 |
|
NCBI chr 7:58,963,319...58,996,357
Ensembl chr 7:57,077,830...57,110,892
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
TNF protein affects the reaction [vadimezan affects the metabolism of Thalidomide]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF mRNA]]; vadimezan affects the reaction [P2RX1 protein affects the reaction [Acetaminophen results in increased expression of TNF protein]] vadimezan results in increased expression of TNF mRNA vadimezan results in increased expression of TNF protein |
CTD |
PMID:15060740 PMID:16944150 PMID:36958387 PMID:37046119 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression |
EXP |
vadimezan results in increased expression of VEGFA protein |
CTD |
PMID:16944150 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity multiple interactions increases export increases transport |
ISO EXP |
Xanthenes results in decreased activity of ABCB1 protein closantel results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; Ivermectin results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; Rafoxanide results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; triclabendazole results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; triclabendazole sulfoxide results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes]; valspodar results in increased susceptibility to [ABCB1A protein results in increased transport of Xanthenes] [valspodar results in decreased activity of ABCB1 protein] which results in decreased transport of Xanthenes [valspodar results in decreased activity of ABCB1 protein] which results in decreased transport of Xanthenes; Calcium deficiency inhibits the reaction [ABCB1 protein results in increased export of Xanthenes] ABCB1 protein results in increased transport of Xanthenes |
CTD |
PMID:18686201 PMID:20041016 PMID:20513441 PMID:21436125 PMID:25862123 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
EXP ISO |
Xanthenes binds to and results in increased activity of AHR protein |
CTD |
PMID:21431309 PMID:28186253 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
decreases activity |
ISO |
Xanthenes results in decreased activity of CYP3A4 protein |
CTD |
PMID:18686201 PMID:20041016 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity |
ISO |
Xanthenes results in decreased activity of UGT1A6 protein |
CTD |
PMID:18686201 PMID:20041016 |
|
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
multiple interactions |
EXP |
xanthone inhibits the reaction [[Isoproterenol results in decreased activity of ACE2 protein] which results in decreased abundance of angiotensin I (1-7)]; xanthone inhibits the reaction [Isoproterenol results in decreased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased expression of ACE2] |
CTD |
PMID:25205467 PMID:36414029 |
|
NCBI chr X:33,925,458...33,972,851
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
xanthone inhibits the reaction [Isoproterenol results in increased expression of ACTA2 protein] |
CTD |
PMID:36414029 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
xanthone inhibits the reaction [Isoproterenol results in increased expression of AGT protein] |
CTD |
PMID:36414029 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
xanthone inhibits the reaction [Isoproterenol results in increased expression of IL6 protein] |
CTD |
PMID:36414029 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
xanthone inhibits the reaction [LEP protein results in increased activity of ACE2 protein]; xanthone inhibits the reaction [LEP protein results in increased expression of ACE2] |
CTD |
PMID:25205467 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions |
EXP |
xanthone inhibits the reaction [Isoproterenol results in increased expression of MIR122 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr18:61,028,817...61,028,901
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
EXP |
xanthone inhibits the reaction [Isoproterenol results in decreased expression of PRKAA2 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Sirt6 |
sirtuin 6 |
multiple interactions |
EXP |
xanthone inhibits the reaction [Isoproterenol results in decreased expression of SIRT6 mRNA] |
CTD |
PMID:36414029 |
|
NCBI chr 7:8,733,056...8,738,543
Ensembl chr 7:8,082,364...8,098,914
|
|
G |
Tnni3 |
troponin I3, cardiac type |
multiple interactions |
EXP |
xanthone inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein] |
CTD |
PMID:36414029 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
|
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of FOS protein] |
CTD |
PMID:21232528 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased ubiquitination of and results in increased degradation of IRAK1 protein] |
CTD |
PMID:21232528 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of JUN protein] |
CTD |
PMID:21232528 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:21232528 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:21232528 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Xanthones inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] |
CTD |
PMID:21232528 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|